Antineoplastic Resistance

Antineoplastic resistance, often used interchangeably with chemotherapy resistance, is the multiple drug resistance of neoplastic (cancerous) cells, or the ability of cancer cells to survive and grow despite anti-cancer therapies.

  • Tumor heterogeneity
  • Mechanisms of acquired antineoplastic resistance
  • Genetic markers for drug sensitivity and resistance
  • Genetic approaches to overcome drug resistance

Related Conference of Antineoplastic Resistance

June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 24-25, 2024

7th International Conference on Anti-Cancer Drugs

Vancouver, Canada
February 24 - 25

Cancer Center Business Summit

Phoenix USA
July 14-15 2016

International Conference on Nuclear Medicine Radiation Therapy

Cologne Germany
May 4-6 2016

Accelerating Anticancer Agent Development and Validation Workshop

Bethesda USA
June 23 - 25 2016

The MASCC ISOO Annual Meeting on Supportive Care in Cancer

Adelaide Australia
November 29 - December 2

EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium

Munich Germany
May 23 - 24 2016

18th International Conference on Medical Microbiology Antimicrobial Agents and Chemotherapy

London United Kingdom
Jan 15-16 2016

Cancer Survivorship Symposium Advancing Care and Research A Primary Care and Oncology Symposium

San Francisco USA
May 4-6 2016

Accelerating Anticancer Agent Development and Validation Workshop

Bethesda USA

Antineoplastic Resistance Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in